NIH-funded research R01 grant

Understanding and treating congenital aortic valve disease

Official title: Mechanisms and Therapeutics for Congenital Aortic Valve Disease

Funded at Research Inst Nationwide Children's Hosp · NIH-11133027 · Data updated 2026-11-12

This study is looking into congenital aortic valve disease to understand what causes it and to find new treatments that might help people avoid surgery, especially by exploring genetic factors and potential medications.

More Aortic Valve Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp
NIH-funded
Lab location1 site (Columbus, United States)
Project startJuly 5, 2024
Project endApril 30, 2028
Funding year2025
Award (this year)$598,341
NIH project number5R01HL175924-02
Project IDNIH-11133027 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with congenital aortic valve disease, particularly those with bicuspid aortic valve or aortic valve stenosis.

Less likely to help

Patients with acquired aortic valve disease or those without congenital heart defects may not benefit from this research.

What this research studies

This research investigates congenital aortic valve disease, focusing on the mechanisms behind its development and potential therapeutic options. It aims to identify genetic factors, such as NOTCH1 and GATA5, that contribute to this condition, which affects heart valve formation. The study will explore pharmacologic therapies that could reduce the need for surgical interventions in patients with aortic valve stenosis. By utilizing both human genetic studies and murine models, the research seeks to uncover new treatment pathways for affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to new medications that prevent the need for surgery in patients with congenital aortic valve disease.

How similar studies have gone: Previous research has successfully identified genetic links to congenital heart defects, suggesting that this approach may yield valuable insights and advancements.

Where this research is happening

  • Research Inst Nationwide Children's Hosp
    Columbus, United States
    Active

Researchers

  • Principal investigator: Garg, Vidu — Research Inst Nationwide Children's Hosp
  • Study coordinator: Garg, Vidu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.